Cronos Group Inc. (CRON) Form 10-Q — Nov 5, 2026
Cronos Group reported Q3 2026 net revenue of $63.5 million, up 75% year over year, with Adjusted EBITDA of $17.1 million versus $5.7 million in the prior-year quarter. Growth was driven by higher cannabis flower sales in Israel and Germany and stronger Canadian volumes, lifting gross margin to 50.9%. Nine-month net revenue reached $161.7 million, up 58%, with net income of $69.2 million. The company repurchased 15.5 million shares for $42.3 million year to date under its $50 million buyback and completed the €57.5 million CanAdelaar acquisition in the Netherlands after quarter-end.
Key figures
- Eps
- 0.04
- Revenue
- 63450000
- Net Income
- 17826000
- Revenue Yoy
- 75%
- Total Assets
- 1198009000
- Cash Position
- 411191000
- Shares Outstanding
- 367528366
- Nine month eps
- 0.16
- Buybacks q3 usd
- 9410000
- Gross margin q3
- 50.9%
- Buybacks ytd usd
- 42268000
- Adjusted ebitda q3
- 17076000
- Buybacks q3 shares
- 3203846
- Nine month net income
- 69200000
- Net revenue nine months
- 161667000
- Adjusted ebitda q3 prior
- 5677000
- Class action settlement usd
- 10000000
- Canadelaar purchase price eur
- €57.5 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.